Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|12|10|985-988

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.12, Iss.10, 2011-12, pp. : 985-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 457-468

Bentham Science Publishers

Access to resources Recommend Favorite

PET Radiotracers for Molecular Imaging in Dementia

By  

Current Radiopharmaceuticals, Vol. 6, Iss. 4, 2013-12 ,pp. : 215-230

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer

By Chi Kim   Chia Stephen   Dixon Ross   Newman Michael   Wacher Vince   Sikic Branimir   Gelmon Karen  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 311-315

Springer Publishing Company

Access to resources Recommend Favorite

Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications

By Lin J.H.   Yamazaki M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 1, 2003-01 ,pp. : 59-98

Adis International

Access to resources Recommend Favorite

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe   Schmitz Volker   Haschke Manuel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite